Compare IDEXX Laboratories, Inc. (IDXX) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Lufax Holding Ltd — how do they compare? IDEXX Laboratories, Inc. trades at $512.76 (market cap $40.43B), while Lufax Holding Ltd trades at $0.96 (market cap $982.89M). The key difference: IDEXX Laboratories, Inc. is far larger — about 41.1× Lufax Holding Ltd's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 3,323,384). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Lufax Holding Ltd for 13 Days on average.
| IDXX | LU | |
|---|---|---|
Market Cap | $40.43B | $982.89M |
Volume | 692,164 | 3,323,384 |
Sector | Health | Financials |
52-Week High | $766.68 | $3.93 |
52-Week Low | $504.70 | $0.95 |
Typical Hold Time | 46 Days | 13 Days |
Enterprise Value | $41.32B | $58.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $506.67, down 1.7% on the day, with technical indicators showing bearish momentum despite strong fundamental performance. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding expectations of $3.94. Recent developments include the acquisition of CoVetAI to enhance veterinary workflow intelligence and expansion of diagnostic testing platforms internationally. Revenue growth remains robust at $4.3 billion for 2025, with net income margins exceeding 25%.
The stock presents a compelling growth story with strong profitability metrics and analyst consensus pointing to significant upside potential (average price target $665). However, current technical weakness and premium valuations (P/E 36.06) create near-term headwinds. Key risks include foreign exchange pressures and potential slowdown in U.S. veterinary visits, while institutional ownership trends show mixed positioning among major funds.
LU trades at $0.9814, down 2.83% on the day, with a bearish technical signal from moving averages but a bullish signal from oscillators. The company reported a net loss of $2.10 billion on revenue of $23.11 billion in 2025, with negative profit margins and ROE. A 10:1 reverse stock split was implemented on October 23, 2026, and recent news highlights ongoing restructuring and regulatory challenges in China's consumer lending market.
The outlook remains challenging due to persistent losses and revenue declines, but deep value is suggested by a low P/B of 0.07 and significant analyst buy ratings (69%). Key risks include regulatory tightening and liquidity shocks in China, while potential catalysts include balance sheet strength and operational improvements under parent company Ping An's backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
